Robert Lorne Hopfner insider trades

Open-market stock purchases and sales by Robert Lorne Hopfner, Director, 10% Owner at Evommune, Inc, from SEC Form 4 filings since Jun 11, 2020.

Track record: 67% of 3 scored buys are up 5% or more since purchase, averaging +90%.

Recent trades

DateStockTradeValue
Dec 19, 2025EVMN Evommune, IncBought$17.4K
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—

Companies traded

  • EVMN Evommune, Inc: 1 buy, last Dec 19, 2025
  • INZY Inozyme Pharma, Inc: 9 buys, last Jul 1, 2025
  • RLYB Rallybio Corp: 1 buy, last May 13, 2025
  • PCVX Vaxcyte, Inc: 1 buy, 40 sales, last Jun 2, 2021

Get free alerts when Robert Lorne Hopfner files a new trade →